1. Home
  2. AD vs ICUI Comparison

AD vs ICUI Comparison

Compare AD & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Array Digital Infrastructure Inc.

AD

Array Digital Infrastructure Inc.

N/A

Current Price

$49.04

Market Cap

4.2B

ML Signal

N/A

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

HOLD

Current Price

$151.76

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AD
ICUI
Founded
1983
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical/Dental Instruments
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
3.6B
IPO Year
N/A
1992

Fundamental Metrics

Financial Performance
Metric
AD
ICUI
Price
$49.04
$151.76
Analyst Decision
Strong Buy
Buy
Analyst Count
3
5
Target Price
$60.33
$179.50
AVG Volume (30 Days)
361.5K
245.2K
Earning Date
02-20-2026
02-19-2026
Dividend Yield
68.20%
N/A
EPS Growth
N/A
N/A
EPS
0.18
N/A
Revenue
$3,795,787,000.00
$2,320,363,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$28.22
N/A
P/E Ratio
$270.77
N/A
Revenue Growth
252.49
N/A
52 Week Low
$44.03
$107.00
52 Week High
$79.17
$165.17

Technical Indicators

Market Signals
Indicator
AD
ICUI
Relative Strength Index (RSI) 44.40 52.99
Support Level $48.00 $148.71
Resistance Level $49.79 $154.79
Average True Range (ATR) 1.49 4.65
MACD -0.28 -0.31
Stochastic Oscillator 20.56 37.28

Price Performance

Historical Comparison
AD
ICUI

About AD Array Digital Infrastructure Inc.

Array Digital Infrastructure, formerly US Cellular, sold its regional wireless operations serving about 4.4 million customers to T-Mobile in August 2025. The firm has agreed to sell most of its remaining spectrum licenses to Verizon and AT&T; however, it will still retain rights to C-band spectrum in several locations after these deals are closed. Array also owns a 5.5% stake in Verizon Wireless' Los Angeles operations and about 4,400 wireless towers.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Share on Social Networks: